Those who are unfamiliar with Elizabeth Berry-Kravis, MD and PhD, she is the Co-Director of the Molecular Diagnostics Section of the Genetic Laboratory at Rush University. ... Berry-Kravis has a history of studying Fragile X and established the comprehensive Fragile X Clinic and Research Program at Rush University in 1992.

More recently, a $4 million cooperative agreement to “Characterize the Natural History of Fragile X Syndrome to Inform the Development of Intervention and Outcome Measures” was awarded to Dr. Elizabeth Berry-Kravis of Rush University Medical Center by the Centers for Disease Control and Prevention (CDC).